Clinical studies have indicated that the levels of IFN-γ, IL-6, TNF-α, IL-2, MCP-1, and other pro-inflammatory cytokines are significantly increased in severe or critical COVID-19 patients. This evidence concerns the gene IL6 and COVID-19.